ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析

◆英語タイトル:ConforMIS Inc (CFMS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME2164FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDuo a customized bicompartmental knee replacement system. ConforMISalso provides iUni a customized unicompartmental knee replacement product, and iTotal Hip a hip replacement product candidate, among others. The company markets its products through a network of sales representatives and distributors across the US, Germany and the UK. The company operates through its manufacturing facility in Wilmington, Massachusetts. ConforMIS is headquartered in Billerica, Massachusetts, the US.

ConforMIS Inc Key Recent Developments

Apr 07,2021: Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
Mar 03,2021: Conformis reports fourth quarter and year end 2020 financial results
Mar 01,2021: Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
Jan 21,2021: Conformis and SITES Medical announce development & supply agreement
Nov 09,2020: Conformis announces Bart Lagae as VP, international sales & marketing; inducement grant reported

This comprehensive SWOT profile of ConforMIS Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ConforMIS Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

ConforMIS Inc – Key Information
ConforMIS Inc – Overview
ConforMIS Inc – Key Employees
ConforMIS Inc – Key Employee Biographies
ConforMIS Inc – Key Operational Heads
ConforMIS Inc – Major Products and Services
ConforMIS Inc – History
ConforMIS Inc – Company Statement
ConforMIS Inc – Locations And Subsidiaries
ConforMIS Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

ConforMIS Inc – Business Description
ConforMIS Inc – Corporate Strategy
ConforMIS Inc – SWOT Analysis
SWOT Analysis – Overview
ConforMIS Inc – Strengths
ConforMIS Inc – Weaknesses
ConforMIS Inc – Opportunities
ConforMIS Inc – Threats
ConforMIS Inc – Key Competitors

Section 3 – Company Financial Performance Charts

ConforMIS Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

ConforMIS Inc, Key Information
ConforMIS Inc, Key Ratios
ConforMIS Inc, Share Data
ConforMIS Inc, Major Products and Services
ConforMIS Inc, History
ConforMIS Inc, Key Employees
ConforMIS Inc, Key Employee Biographies
ConforMIS Inc, Key Operational Heads
ConforMIS Inc, Other Locations
ConforMIS Inc, Subsidiaries
ConforMIS Inc, Key Competitors
ConforMIS Inc, SWOT Analysis
ConforMIS Inc, Ratios based on current share price
ConforMIS Inc, Annual Ratios
ConforMIS Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ConforMIS Inc (CFMS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 2020 GeneSystems Inc-医療機器分野:企業M&A・提携分析
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. The company provides tests in the areas such as personalized medicine, earl …
  • C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析
    Summary C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral …
  • Cracker Barrel Old Country Store, Inc. (CBRL):企業の財務・戦略的SWOT分析
    Cracker Barrel Old Country Store, Inc. (CBRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • CITGO Petroleum Corporation:企業の戦略・SWOT・財務情報
    CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • JM AB:企業の戦略・SWOT・財務情報
    JM AB - Strategy, SWOT and Corporate Finance Report Summary JM AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • CeoTronics AG (CEK):企業の財務・戦略的SWOT分析
    CeoTronics AG (CEK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Meridian Energy Limited:企業の戦略・SWOT・財務分析
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ACMAT Corporation:企業の戦略・SWOT・財務情報
    ACMAT Corporation - Strategy, SWOT and Corporate Finance Report Summary ACMAT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Altimmune Inc-製薬・医療分野:企業M&A・提携分析
    Summary Altimmune Inc (Altimmune), formerly Vaxin Inc is a biotechnology company that develops vaccines and other biological products. The company's products include novel vaccine delivery platforms, immunotherapeutic products, intranasally administered recombinant influenza vaccine, traditional inf …
  • C&S Wholesale Grocers, Inc.:企業の戦略・SWOT・財務分析
    C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report Summary C&S Wholesale Grocers, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Huishang Bank Corp Ltd:企業の戦略・SWOT・財務分析
    Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Baxter International Inc (BAX):医療機器:M&Aディール及び事業提携情報
    Summary Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemos …
  • Lensar Inc-医療機器分野:企業M&A・提携分析
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the …
  • Culp Inc (CULP):企業の財務・戦略的SWOT分析
    Culp Inc (CULP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Merck & Co., Inc.:企業の戦略・SWOT・財務情報
    Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Clarion Co., Ltd. (6796):企業の財務・戦略的SWOT分析
    Clarion Co., Ltd. (6796) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Relisys Medical Devices Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Relisys Medical Devices Ltd (Relisys), formerly Care Polymed Ltd is a medical device company that develops, manufactures and commercializes catheter products. The company’s products include drug eluting stent systems, bare metal stent systems, PTCA catheters and angiographic catheters. Its a …
  • The Save Mart Companies:戦略・SWOT・企業財務分析
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆